Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

COPOVIDONE CRS (60 MG)

COPOVIDONE CRS (60 MG)

ND

DISCOVER
ZOLPIDEM FOR SYSTEM SUITABILITY CRS - * PSY (ZOLPIDEM TARTRA

ZOLPIDEM FOR SYSTEM SUITABILITY CRS - * PSY (ZOLPIDEM TARTRA

ND

DISCOVER
ALMOTRIPTAN FOR SYSTEM SUITABILITY CRS (10 MG)

ALMOTRIPTAN FOR SYSTEM SUITABILITY CRS (10 MG)

ND

DISCOVER
FLUOCORTOLONE  PIVALATE FOR ID AND ASSAY CRS (110 MG)

FLUOCORTOLONE PIVALATE FOR ID AND ASSAY CRS (110 MG)

ND

DISCOVER
CATALPOL CRS (15 MG)

CATALPOL CRS (15 MG)

ND

DISCOVER
SENNOSIDE B CRS (15 MG)

SENNOSIDE B CRS (15 MG)

ND

DISCOVER
ALMOTRIPTAN MALATE CRS (70 MG)

ALMOTRIPTAN MALATE CRS (70 MG)

ND

DISCOVER
TESTOSTERONE IMPURITY I CRS (20 MG)

TESTOSTERONE IMPURITY I CRS (20 MG)

ND

DISCOVER
ROSUVASTATIN FOR IMPURITY L IDENTIFICATION CRS (10 MG)

ROSUVASTATIN FOR IMPURITY L IDENTIFICATION CRS (10 MG)

ND

DISCOVER
MERCAPTOPURINE IMPURITY A CRS(15 MG)

MERCAPTOPURINE IMPURITY A CRS(15 MG)

ND

DISCOVER
MERCAPTOPURINE IMPURITY B CRS(15 MG)

MERCAPTOPURINE IMPURITY B CRS(15 MG)

ND

DISCOVER
TRANEXAMIC ACID IMPURITY E CRS (10 MG)

TRANEXAMIC ACID IMPURITY E CRS (10 MG)

ND

DISCOVER